OBSERVATIONAL CROSS SECTIONAL STUDY INVESTIGATING THE PREVALENCE OF FABRY DISEASE IN CHRONIC STABLE DIALYSIS POPULATION (FIDS).

G RAMAN1, J WONG1, A MALLAWAARACHCHI1, C LOPEZ1, K ESPINOZA1, A MAKRIS1

1Sydney South West Area Health Service, New South Wales, Australia

Aim: Establish the prevalence of Fabry Disease in chronic stable dialysis patients in South West Sydney Local Health District (SWSLHD) and to compare two diagnostic laboratories (Lab A and Lab B) for Fabry disease.

Background: Fabry disease is a rare genetic lysosomal storage disease due to complete or partial alpha-galactosidase A (A-GAL A) deficiency resulting in accumulation of globotrisylceramide (GB3) and end organ dysfunction including renal failure. Diagnosis is based on assessing enzyme activity (Labs A and B) or in combination with genetic testing via massively parallel sequencing of the GLA gene (Lab B).

Methods: A 6 month observational cross-sectional study of prevalent SWSLHD dialysis patients was commenced in February 2017. Dried blood spots (DBS) were collected and dispatched to Labs A &B as per manufacturer’s instructions.

Results: To date 102 haemodialysis patients were approached, 27 were unable to consent and 5 declined to participate. 70 patients (20 female and 50 male) were tested thus far.  Lab A identified 16 (2 male, 14 female) patients with low A-GAL-A activity however 6 of these also reported low control enzyme activity. Lab B also reported low A-GAL-A activity in 24 males. All females and males with low enzyme activity underwent genetic testing and were found to be negative.

Conclusions:  Low a-GAL-A activity by DBS is common in haemodialysis patients, resulting in false positives mandating a genetic test to confirm the diagnosis of Fabry disease in this population. Lab B provides a more definitive answer.

About ANZSN

The ASM is hosted by Australian and New Zealand Society of Nephrology.

The aims of the Society are to promote and support the study of the kidney and urinary tract in health and disease, and to ensure the highest professional standards for the practice of nephrology in Australia and New Zealand.

Conference Managers

Please contact the team at Conference Design with any questions regarding the conference.
/wp-content/uploads/2017/08/Conference-Design-400x400.png
© 2015 - 2016 Conference Design Pty Ltd